Sumitomo Mitsui Trust Holdings, Inc. Alnylam Pharmaceuticals, Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

  • $168 Billion
  • Q3 2025

A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 314,452 shares of ALNY stock, worth $141 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
314,452
Previous 293,542 7.12%
Holding current value
$141 Million
Previous $95.7 Million 49.8%
% of portfolio
0.09%
Previous 0.06%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 27, 2025
BUY
$311.12 - $482.13 $6.51 Million - $10.1 Million
20,910 Added 7.12%
314,452 $143 Million
Q2 2025

Jul 31, 2025
BUY
$224.32 - $326.09 $463,445 - $673,701
2,066 Added 0.71%
293,542 $95.7 Million
Q1 2025

Apr 25, 2025
BUY
$233.07 - $290.7 $1.11 Million - $1.39 Million
4,773 Added 1.66%
291,476 $78.7 Million
Q4 2024

Jan 28, 2025
BUY
$232.27 - $300.43 $1.97 Million - $2.54 Million
8,462 Added 3.04%
286,703 $67.5 Million
Q3 2024

Nov 05, 2024
BUY
$233.81 - $287.01 $302,550 - $371,390
1,294 Added 0.47%
278,241 $76.5 Million
Q2 2024

Jul 19, 2024
SELL
$143.31 - $247.0 $2.01 Million - $3.47 Million
-14,049 Reduced 4.83%
276,947 $67.3 Million
Q1 2024

Apr 19, 2024
SELL
$146.51 - $198.2 $627,502 - $848,890
-4,283 Reduced 1.45%
290,996 $43.5 Million
Q4 2023

Jan 30, 2024
SELL
$151.41 - $196.57 $215,153 - $279,325
-1,421 Reduced 0.48%
295,279 $56.5 Million
Q3 2023

Oct 30, 2023
SELL
$170.77 - $211.65 $329,415 - $408,272
-1,929 Reduced 0.65%
296,700 $52.5 Million
Q2 2023

Jul 31, 2023
SELL
$185.01 - $212.05 $7.83 Million - $8.98 Million
-42,338 Reduced 12.42%
298,629 $56.7 Million
Q1 2023

Apr 27, 2023
BUY
$182.66 - $235.53 $728,996 - $940,000
3,991 Added 1.18%
340,967 $68.3 Million
Q4 2022

Jan 30, 2023
SELL
$185.53 - $241.31 $317,070 - $412,398
-1,709 Reduced 0.5%
336,976 $80.1 Million
Q3 2022

Oct 21, 2022
BUY
$138.54 - $232.0 $116,789 - $195,576
843 Added 0.25%
338,685 $67.8 Million
Q2 2022

Jul 26, 2022
BUY
$120.42 - $169.29 $1.82 Million - $2.56 Million
15,099 Added 4.68%
337,842 $49.3 Million
Q1 2022

Apr 27, 2022
SELL
$127.18 - $173.91 $217,350 - $297,212
-1,709 Reduced 0.53%
322,743 $52.7 Million
Q4 2021

Feb 02, 2022
SELL
$159.56 - $209.29 $1.3 Million - $1.7 Million
-8,119 Reduced 2.44%
324,452 $55 Million
Q3 2021

Oct 25, 2021
SELL
$169.75 - $207.73 $2.6 Million - $3.19 Million
-15,344 Reduced 4.41%
332,571 $62.8 Million
Q2 2021

Aug 02, 2021
SELL
$128.63 - $176.89 $2.89 Million - $3.97 Million
-22,469 Reduced 6.07%
347,915 $59 Million
Q1 2021

Apr 30, 2021
SELL
$126.83 - $175.69 $1.4 Million - $1.94 Million
-11,027 Reduced 2.89%
370,384 $52.3 Million
Q4 2020

Feb 05, 2021
SELL
$122.97 - $147.0 $7.54 Million - $9.01 Million
-61,284 Reduced 13.84%
381,411 $49.6 Million
Q3 2020

Oct 30, 2020
SELL
$121.19 - $165.49 $14.1 Million - $19.3 Million
-116,349 Reduced 20.81%
442,695 $64.5 Million
Q2 2020

Jul 27, 2020
SELL
$104.21 - $156.44 $17.8 Million - $26.7 Million
-170,925 Reduced 23.42%
559,044 $82.8 Million
Q1 2020

Apr 27, 2020
BUY
$93.12 - $133.99 $26.7 Million - $38.4 Million
286,933 Added 64.77%
729,969 $79.5 Million
Q4 2019

Jan 31, 2020
BUY
$74.51 - $124.23 $641,009 - $1.07 Million
8,603 Added 1.98%
443,036 $51 Million
Q3 2019

Oct 31, 2019
BUY
$70.9 - $87.82 $6.13 Million - $7.59 Million
86,454 Added 24.84%
434,433 $34.9 Million
Q2 2019

Jul 29, 2019
SELL
$65.86 - $92.79 $199,819 - $281,524
-3,034 Reduced 0.86%
347,979 $25.2 Million
Q1 2019

May 08, 2019
BUY
$72.76 - $93.45 $2.29 Million - $2.94 Million
31,459 Added 9.84%
351,013 $32.8 Million
Q4 2018

Feb 06, 2019
BUY
$62.67 - $88.33 $3.27 Million - $4.6 Million
52,110 Added 19.48%
319,554 $22.5 Million
Q3 2018

Nov 07, 2018
SELL
$87.52 - $122.67 $337,039 - $472,402
-3,851 Reduced 1.42%
267,444 $23.4 Million
Q2 2018

Aug 01, 2018
BUY
$88.31 - $107.8 $1.42 Million - $1.74 Million
16,110 Added 6.31%
271,295 $26.7 Million
Q1 2018

May 01, 2018
BUY
$115.92 - $148.54 $1.78 Million - $2.28 Million
15,369 Added 6.41%
255,185 $30.4 Million
Q4 2017

Feb 06, 2018
BUY
$114.49 - $139.98 $27.5 Million - $33.6 Million
239,816
239,816 $30.5 Million

Others Institutions Holding ALNY

# of Institutions
916
Shares Held
117M
Call Options Held
1.25M
Put Options Held
1.49M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $55.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email